Akouos Company

Akouos is a biotechnology company focusing on restoring and preserving hearing. The company leverages adeno-associated viral (AAV) vector-based gene therapy in order to restore and preserve hearing in genetically-defined patient populations in a range of forms, from a single genetic mutation to ototoxic drug exposure and to the aging process, enabling the healthcare industry to treat sensorineural hearing loss in an efficient manner.
Industry:
BioTech
Technology:
Neurological Disorders
Funding Status:
IPO
Estimated Revenue:
$1M to $10M
Headquarters:
Boston, Massachusetts, United States
Employee Number:
51-100
Investor Type:
For Profit
Total Funding:
137550000
Founded Date:
2017-01-01
Last Funding Type:
Series B